Lobby organisation
CSL
Company · Health & pharma · HQ: Australia · website · Transparency Register entry
As of 8 October 2026, CSL appears in 19 declared MEP meetings (15 different MEPs), most often with European People's Party.
In their own words
“CSL is a global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology.”
Read the rest of the statementShow less of the statement
“Since our start in 1916, we have been driven by our promise to save lives using the latest technologies and delivering critical medicines, such as gene therapy and plasma derived therapies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000 people. Please note that CSL Behring and CSL Vifor are integrating under a new entity, legal group entity, CSL. Therefore, we have updated the transparency registry entry of CSL Behring (030031840349 92) to merge it with Vifor (283361852096 45). Therefore, the previous Vifor entry (283361852096 45) has now been deleted and integrated under the new CSL entry (030031840349 92).”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 19 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2025. Bar length is relative to its busiest year (16 in 2025).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 20 Nov 2025 | Seán Kelly | Discussing opportunities for co=operation and investment between Australian and European pharmaceutical firms |
| 3 Sep 2025 | Marion Walsmann | CMA |
| 17 Jul 2025 | Tiemo Wölken | Critical Medicines Act |
| 15 Jul 2025 | Andreas Glück | CMA |
| 8 Jul 2025 | Vlad Vasile-Voiculescu | Meeting CMA |
| 3 Jul 2025 | András Tivadar Kulja | Critical medicines act |
| 25 Jun 2025 | Mohammed Chahim | Roundtable Critical Medicines Act |
| 19 May 2025 | Oliver Schenk | Critical Medicines Act |
| 14 May 2025 | Tomislav Sokol | Health policy |
| 12 May 2025 | Andreas Glück | Critical Medicines |
| 29 Apr 2025 | Oliver Schenk | Pharmaceutical Industry in the EU |
| 8 Apr 2025 | Michalis Hadjipantela | Introductory Meeting - Rare Diseases |
| 7 Apr 2025 | Elena Nevado del Campo | Health priorities |
| 26 Mar 2025 | Aurelijus Veryga | Critical Medicines Act and Availability of Essential Medicines in the EU |
| 10 Mar 2025 | Stine Bosse | European health policy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.